drugset / Trial / NCT00679770
Study of Different Doses of a Novel Treatment for Onychomycosis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of the study is to determine the safety and efficacy of 2.5%, 5.0%, and 7.5% AN2690 Solutions compared to the vehicle alone in the treatment of distal, subungual onychomycosis of the great target toenail.
Timeline
- Start
- 2006-06-30
- Primary completion
- 2007-08-31
- Completion
- 2007-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tavaborole | Small molecule | 2.5 % | Topical |
| Subject | Tavaborole | Small molecule | 5 % | Topical |
| Subject | Tavaborole | Small molecule | 7.5 % | Topical |